The company’s silica for chromatography, NLAB Saga®, has been developed to meet the expectations of industrial scale purification by chromatography. An optimized combination of pore volume, high available surface area and ligand density, and high carbon load results in a robust and reliable product with stellar performance. Due to its exceptional mechanical and chemical stability, NLAB Saga® is an excellent choice for the purification of peptides such as insulin, insulin analogues and GLP-1 analogues.
The NLAB Saga® silica has a high loading capacity and low backpressure, well suited for preparative use and is easy to pack.
Nanologica has full control of the entire manufacturing process, from raw material to finished product. NLAB Saga® has been tested and used by pharmaceutical companies manufacturing APIs at industrial scale, where quality, performance and durability are uncompromisable.
We take great pride in the quality and performance of our products – they embody our core values:
Swedish Excellence in Nanoporous Silica.
Properties of NLAB Saga®
- Perfectly spherical, fully porous silica
- Exceptional chemical stability at high and low pH
- Excellent mechanical stability
- High loading capacity
- Smooth surface with evenly distributed silanol groups
- Tightly controlled particle size
- High purity silica – very low metal content
- High carbon content
The NLAB Saga® silica for preparative chromatography is produced at the contract manufacturer Sterling Pharma Solutions in the UK, using Nanologica’s proprietary manufacturing process. At the multi-ton production facility, Nanologica has full control of the manufacturing process in each step. This enables a sustainable production of silica batches with excellent properties for the purification of peptides.